• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤患者接受全疗程治疗后,骨盆大的溶骨性病变出现广泛再矿化。

Extensive Remineralization of Large Pelvic Lytic Lesions Following Total Therapy Treatment in Patients With Multiple Myeloma.

作者信息

Mohan Meera, Samant Rohan S, Yoon Donghoon, Buros Amy F, Branca Antonio, Montgomery Corey O, Nicholas Richard, Suva Larry J, Morello Roy, Thanendrarajan Sharmilan, Schinke Carolina, Yaccoby Shmuel, van Rhee Frits, Davies Faith E, Morgan Gareth J, Zangari Maurizio

机构信息

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Department of Radiology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

出版信息

J Bone Miner Res. 2017 Jun;32(6):1261-1266. doi: 10.1002/jbmr.3111. Epub 2017 Mar 27.

DOI:10.1002/jbmr.3111
PMID:28240368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5466479/
Abstract

Osteolytic bone lesions are a hallmark of multiple myeloma (MM) bone disease. Bone destruction is associated with severely imbalanced bone remodeling, secondary to increased osteoclastogenesis and significant osteoblast suppression. Lytic lesions of the pelvis are relatively common in MM patients and are known to contribute to the increased morbidity because of the high risk of fracture, which frequently demands extensive surgical intervention. After observing unexpected radiological improvement in serial large pelvic CT assessment in a patient treated in a total therapy protocol, the radiographic changes of pelvic osteolytic lesions by PET/CT scanning in patients who received Total Therapy 4 (TT4) treatment for myeloma were retrospectively analyzed. Sixty-two (62) patients with lytic pelvic lesions >1 cm in diameter were identified at baseline PET/CT scanning. Follow-up CT studies showed that 27 of 62 patients (43%) with large baseline pelvic lesions achieved significant reaccumulation of radiodense mineralization at the lytic cortical site. The average size of lytic lesions in which remineralization occurred was 4 cm (range, 1.3 to 10 cm). This study clearly demonstrates that mineral deposition in large pelvic lesions occurs in a significant proportion of MM patients treated with TT4, potentially affecting patient outcomes, quality of life, and future treatment strategies. © 2017 American Society for Bone and Mineral Research.

摘要

溶骨性骨病变是多发性骨髓瘤(MM)骨病的一个标志。骨破坏与严重失衡的骨重塑相关,这继发于破骨细胞生成增加和成骨细胞显著受抑制。骨盆的溶骨性病变在MM患者中相对常见,并且已知由于骨折风险高而导致发病率增加,这常常需要广泛的手术干预。在观察到一名接受全疗程治疗方案的患者在系列大骨盆CT评估中出现意外的影像学改善后,对接受骨髓瘤全疗程治疗4(TT4)的患者通过PET/CT扫描观察到的骨盆溶骨性病变的影像学变化进行了回顾性分析。在基线PET/CT扫描时,确定了62例直径>1 cm的骨盆溶骨性病变患者。随访CT研究显示,62例基线骨盆大病变患者中有27例(43%)在溶骨性皮质部位实现了放射性致密矿化的显著再蓄积。发生再矿化的溶骨性病变的平均大小为4 cm(范围为1.3至10 cm)。这项研究清楚地表明,在接受TT4治疗的MM患者中,很大一部分患者的大骨盆病变中发生了矿物质沉积,这可能会影响患者的预后、生活质量和未来的治疗策略。©2017美国骨与矿物质研究学会。

相似文献

1
Extensive Remineralization of Large Pelvic Lytic Lesions Following Total Therapy Treatment in Patients With Multiple Myeloma.多发性骨髓瘤患者接受全疗程治疗后,骨盆大的溶骨性病变出现广泛再矿化。
J Bone Miner Res. 2017 Jun;32(6):1261-1266. doi: 10.1002/jbmr.3111. Epub 2017 Mar 27.
2
Bone remineralization of lytic lesions in multiple myeloma - The Arkansas experience.多发性骨髓瘤溶骨性病变的骨再矿化 - 阿肯色州的经验。
Bone. 2021 May;146:115876. doi: 10.1016/j.bone.2021.115876. Epub 2021 Feb 6.
3
Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography.使用计算机断层扫描对接受新型药物治疗的多发性骨髓瘤患者的简化反应监测标准。
Eur J Radiol. 2016 Dec;85(12):2195-2199. doi: 10.1016/j.ejrad.2016.10.015. Epub 2016 Oct 17.
4
(18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.(18)F-FDG 动态 PET/CT 检查在多发性骨髓瘤患者中的应用:示踪剂摄取模式及其与骨髓浆细胞浸润率的相关性。
Clin Nucl Med. 2015 Jun;40(6):e300-7. doi: 10.1097/RLU.0000000000000773.
5
Prognostic value of the bone turnover markers in multiple myeloma.骨转换标志物在多发性骨髓瘤中的预后价值。
Exp Oncol. 2017 Mar;39(1):53-56.
6
PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics.正电子发射断层扫描/计算机断层扫描研究多发性骨髓瘤使用 (18)F-FDG 和 (18)F-NaF:分布模式和示踪剂药代动力学的比较。
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1343-53. doi: 10.1007/s00259-014-2721-y. Epub 2014 Feb 22.
7
Association of osteolytic lesions, bone mineral loss and trabecular sclerosis with prevalent vertebral fractures in patients with multiple myeloma.多发性骨髓瘤患者中溶骨性病变、骨矿物质丢失及小梁硬化与椎体骨折患病率的相关性
Eur J Radiol. 2015 Nov;84(11):2269-74. doi: 10.1016/j.ejrad.2015.07.024. Epub 2015 Aug 6.
8
Identification of focal lesion characteristics in MRI which indicate presence of corresponding osteolytic lesion in CT in patients with multiple myeloma.在多发性骨髓瘤患者的 MRI 中识别提示 CT 中存在相应溶骨性病变的局灶性病变特征。
Bone. 2023 Oct;175:116857. doi: 10.1016/j.bone.2023.116857. Epub 2023 Jul 22.
9
The role of conventional and novel PET radiotracers in assessment of myeloma bone disease.常规和新型 PET 放射性示踪剂在骨髓瘤骨病评估中的作用。
Bone. 2024 Feb;179:116957. doi: 10.1016/j.bone.2023.116957. Epub 2023 Nov 14.
10
Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma.骨髓瘤中FDG PET/CT成像与其他成像方式的比较。
Skeletal Radiol. 2006 Sep;35(9):632-40. doi: 10.1007/s00256-006-0127-z. Epub 2006 Jun 7.

引用本文的文献

1
Recent Advances in Minimally Invasive Management of Osteolytic Periacetabular Skeletal Metastases.溶骨性髋臼周围骨转移瘤微创治疗的最新进展
Semin Intervent Radiol. 2024 Jul 10;41(2):154-169. doi: 10.1055/s-0044-1787165. eCollection 2024 Apr.
2
Assessing Osteolytic Lesion Size on Sequential CT Scans Is a Reliable Study Endpoint for Bone Remineralization in Newly Diagnosed Multiple Myeloma.在连续CT扫描上评估溶骨性病变大小是新诊断多发性骨髓瘤骨再矿化的可靠研究终点。
Cancers (Basel). 2023 Aug 7;15(15):4008. doi: 10.3390/cancers15154008.
3
The Synthetic Collagen-Binding Peptide NIPEP-OSS Delays Mouse Myeloma Progression.

本文引用的文献

1
Bone healing in multiple myeloma: a prospective evaluation of the impact of first-line anti-myeloma treatment.多发性骨髓瘤中的骨愈合:一线抗骨髓瘤治疗影响的前瞻性评估
Haematologica. 2016 Oct;101(10):e419-e422. doi: 10.3324/haematol.2016.144477. Epub 2016 Jun 30.
2
Myeloma today: Disease definitions and treatment advances.多发性骨髓瘤现状:疾病定义和治疗进展。
Am J Hematol. 2016 Jan;91(1):90-100. doi: 10.1002/ajh.24236.
3
Bone formation following lenalidomide-dexamethasone combination therapy in cases of multiple myeloma refractory to high-dose chemotherapy with bortezomib and autologous peripheral blood stem cell transplantation: report of a case and review of the literature.
合成胶原蛋白结合肽NIPEP-OSS延缓小鼠骨髓瘤进展。
Cancers (Basel). 2023 Apr 26;15(9):2473. doi: 10.3390/cancers15092473.
4
Panniculitis and pancreatitis: Inflammation and necrotic mechanisms in a patient with alcohol use disorder and alarming suspicion for malignant process.脂膜炎与胰腺炎:一名患有酒精使用障碍且高度怀疑有恶性病变患者的炎症及坏死机制
Radiol Case Rep. 2023 Feb 8;18(4):1560-1563. doi: 10.1016/j.radcr.2023.01.058. eCollection 2023 Apr.
5
Animal Models of Multiple Myeloma Bone Disease.多发性骨髓瘤骨病的动物模型
Front Genet. 2021 Jun 7;12:640954. doi: 10.3389/fgene.2021.640954. eCollection 2021.
6
Bone remineralization of lytic lesions in multiple myeloma - The Arkansas experience.多发性骨髓瘤溶骨性病变的骨再矿化 - 阿肯色州的经验。
Bone. 2021 May;146:115876. doi: 10.1016/j.bone.2021.115876. Epub 2021 Feb 6.
7
Osteoblast suppression in multiple myeloma bone disease.多发性骨髓瘤骨病中的成骨细胞抑制
J Bone Oncol. 2018 Sep 15;13:62-70. doi: 10.1016/j.jbo.2018.09.001. eCollection 2018 Nov.
来那度胺-地塞米松联合治疗对硼替佐米和自体外周血干细胞移植的大剂量化疗难治的多发性骨髓瘤患者后的骨形成:1例报告及文献综述
Int J Clin Exp Pathol. 2015 Aug 1;8(8):9609-19. eCollection 2015.
4
Reconstruction of multiple myeloma lesions around the pelvis and acetabulum.骨盆和髋臼周围多发性骨髓瘤病变的重建
Eur J Orthop Surg Traumatol. 2015 May;25(4):643-53. doi: 10.1007/s00590-014-1555-4. Epub 2014 Oct 19.
5
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.国际骨髓瘤工作组关于多发性骨髓瘤相关骨病治疗的建议。
J Clin Oncol. 2013 Jun 20;31(18):2347-57. doi: 10.1200/JCO.2012.47.7901. Epub 2013 May 20.
6
Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial.诱导和维持治疗加长期双磷酸盐对多发性骨髓瘤患者骨病的影响:英国医学研究理事会多发性骨髓瘤 IX 临床试验。
Blood. 2012 Jun 7;119(23):5374-83. doi: 10.1182/blood-2011-11-392522. Epub 2012 Apr 12.
7
Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy.循环中骨硬化蛋白水平升高与有症状骨髓瘤的晚期疾病特征和异常骨重塑相关:硼替佐米单药治疗后降低。
Int J Cancer. 2012 Sep 15;131(6):1466-71. doi: 10.1002/ijc.27342. Epub 2011 Dec 21.
8
Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma.硼替佐米联合美法仑-泼尼松与美法仑-泼尼松在多发性骨髓瘤 III 期 VISTA 试验中的骨疾病事件减少、改善骨重塑和骨愈合证据。
Eur J Haematol. 2011 May;86(5):372-84. doi: 10.1111/j.1600-0609.2011.01599.x. Epub 2011 Mar 30.
9
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience.放疗对浆细胞肿瘤缓解疼痛和再钙化的影响:长期经验。
Strahlenther Onkol. 2011 Feb;187(2):114-9. doi: 10.1007/s00066-010-2155-9. Epub 2011 Jan 24.
10
A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients.前瞻性评估硼替佐米治疗多发性骨髓瘤患者的生化、代谢、激素和结构骨变化与反应的关系。
Haematologica. 2011 Feb;96(2):333-6. doi: 10.3324/haematol.2010.031302. Epub 2010 Oct 15.